RDNT
RadNet, Inc.
Company overview
- Market capitalization
- $5.65B
- Employees
- 11,000
- Latest publication
- 2026-09-29
About RadNet, Inc.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 622,720,000USD | 575,631,000USD | 547,712,000USD | 522,869,000USD | 498,230,000USD | 471,399,000USD | 477,101,000USD | 461,142,000USD |
| Total Operating Expenses | 583,252,000USD | 46,804,000USD | 40,852,000USD | 39,799,000USD | 38,266,000USD | 42,020,000USD | 41,140,000USD | 35,431,000USD |
| Operating Income | 39,468,000USD | -16,393,999USD | 35,079,000USD | 32,691,000USD | 30,879,000USD | -24,101,000USD | 24,525,000USD | 33,911,000USD |
| Total Other Income Expense Net | -12,851,000USD | -16,434,000USD | -14,163,000USD | -12,417,000USD | -7,025,000USD | -9,034,000USD | -9,201,000USD | -17,320,000USD |
| Interest Income | 4,200,000USD | — | — | — | — | — | — | — |
| Interest Expense | 18,153,000USD | 17,657,000USD | 18,130,000USD | 17,355,000USD | 17,189,000USD | 17,239,000USD | 18,073,000USD | 19,427,000USD |
| Income Before Tax | 26,617,000USD | -32,828,000USD | 20,916,000USD | 20,274,000USD | 23,854,000USD | -33,135,000USD | 15,324,000USD | 16,591,000USD |
| Income Tax Expense | 6,363,000USD | -8,096,000USD | 11,055,000USD | 6,385,000USD | 820,000USD | -3,398,000USD | 1,099,000USD | 4,335,000USD |
| Equity Method Income Loss | 4,710,000USD | — | — | — | — | — | — | — |
| Net Income | 20,254,000USD | -33,466,000USD | -597,000USD | 5,417,000USD | 14,454,000USD | -37,926,000USD | 5,345,000USD | 3,209,000USD |
| Minority Interest | 12,724,000USD | -8,734,000USD | -10,458,000USD | -8,472,000USD | -8,580,000USD | -8,189,000USD | -8,880,000USD | -9,047,000USD |
| Net Income Applicable To Common Shares | 7,530,000USD | — | — | — | — | — | — | — |
| Cost Of Revenue | — | 592,025,000USD | 471,781,000USD | 450,379,000USD | 429,085,000USD | 453,480,000USD | 411,436,000USD | 391,800,000USD |
| Gross Profit | — | -16,393,999USD | 75,931,000USD | 72,490,000USD | 69,145,000USD | 17,919,000USD | 65,665,000USD | 69,342,000USD |
| Unclassified Operating Expenses | — | 46,804,000USD | 37,290,000USD | 36,237,000USD | 38,266,000USD | 38,458,000USD | 34,508,000USD | 35,431,000USD |
| Net Interest Income | — | -17,657,000USD | -18,130,000USD | -17,355,000USD | -17,189,000USD | -17,239,000USD | -18,073,000USD | -19,427,000USD |
| Tax Provision | — | -8,096,000USD | 11,055,000USD | 6,385,000USD | 820,000USD | -3,398,000USD | 1,099,000USD | 4,335,000USD |
| Net Income From Continuing Ops | — | -24,732,000USD | 9,861,000USD | 13,889,000USD | 23,034,000USD | -29,737,000USD | 14,225,000USD | 12,256,000USD |
| Ebit | — | -16,394,000USD | 39,046,000USD | 37,629,000USD | 41,043,000USD | -15,896,000USD | 29,724,000USD | 36,018,000USD |
| Ebitda | — | 28,573,000USD | 139,765,000USD | 77,428,000USD | 77,036,000USD | 19,587,000USD | 65,739,999USD | 70,997,000USD |
| Depreciation And Amortization | — | 44,967,000USD | 100,719,000USD | 39,799,000USD | 35,993,000USD | 35,483,000USD | 36,015,999USD | 34,979,000USD |
| Reconciled Depreciation | — | 44,967,000USD | 100,719,000USD | 39,799,000USD | 35,993,000USD | 35,483,000USD | 96,568,000USD | 34,979,000USD |
| Research Development | — | — | 3,562,000USD | 3,562,000USD | — | 3,562,000USD | 6,632,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,040,210,000USD | 1,829,664,000USD | 1,616,630,000USD | 1,430,061,000USD | 1,315,077,000USD | 1,071,840,000USD | 1,154,179,000USD | 975,146,000USD |
| Cost Of Revenue | 1,949,406,000USD | 1,580,549,000USD | 1,395,239,000USD | 1,264,346,000USD | 1,123,274,000USD | 965,902,000USD | 999,692,000USD | 867,547,000USD |
| Gross Profit | 90,804,000USD | 249,115,000USD | 221,391,000USD | 165,715,000USD | 191,803,000USD | 105,938,000USD | 154,487,000USD | 107,599,000USD |
| Unclassified Operating Expenses | 1,978,218,000USD | 144,494,000USD | 121,386,000USD | -1,145,940,000USD | -1,014,769,000USD | -900,001,000USD | -916,702,000USD | -796,579,000USD |
| Total Operating Expenses | 1,978,218,000USD | 144,494,000USD | 122,694,000USD | 119,352,000USD | 109,249,000USD | 70,254,000USD | 84,609,000USD | 72,899,000USD |
| Operating Income | 90,804,000USD | 104,621,000USD | 98,697,000USD | 46,363,000USD | 82,554,000USD | 35,684,000USD | 69,878,000USD | 30,886,000USD |
| Interest Expense | 69,913,000USD | 79,849,000USD | 64,483,000USD | 50,841,000USD | 48,830,000USD | 45,882,000USD | 48,044,000USD | 43,456,000USD |
| Net Interest Income | -69,913,000USD | -79,849,000USD | -63,319,000USD | -50,841,000USD | -48,830,000USD | -45,882,000USD | -48,044,000USD | -43,456,000USD |
| Income Before Tax | 31,909,000USD | 44,862,000USD | 38,810,000USD | 42,969,000USD | 58,879,000USD | -854,000USD | 29,669,000USD | 38,527,000USD |
| Income Tax Expense | 14,862,000USD | 6,026,000USD | 8,473,000USD | 9,361,000USD | 14,560,000USD | 895,000USD | 6,229,000USD | 394,000USD |
| Tax Provision | 14,862,000USD | 6,026,000USD | 10,015,000USD | 9,361,000USD | 14,560,000USD | 895,000USD | 6,229,000USD | 394,000USD |
| Net Income | -18,652,000USD | 2,793,000USD | 3,044,000USD | 10,650,000USD | 24,727,000USD | -14,840,000USD | 14,756,000USD | 32,243,000USD |
| Net Income From Continuing Ops | 17,047,000USD | 38,836,000USD | 29,309,000USD | 33,608,000USD | 44,319,000USD | -1,749,000USD | 23,440,000USD | 38,133,000USD |
| Ebit | 90,804,000USD | 124,711,000USD | 103,293,000USD | 93,810,000USD | 107,709,000USD | 45,028,000USD | 77,713,000USD | 34,700,000USD |
| Ebitda | 242,931,000USD | 262,549,000USD | 292,786,000USD | 278,534,000USD | 278,370,000USD | 199,738,000USD | 225,162,000USD | 107,599,000USD |
| Depreciation And Amortization | 152,127,000USD | 137,838,000USD | 189,493,000USD | 184,724,000USD | 170,661,000USD | 154,710,000USD | 147,449,000USD | 72,899,000USD |
| Reconciled Depreciation | 211,994,000USD | 198,390,000USD | 191,189,000USD | 184,724,000USD | 170,661,000USD | 154,710,000USD | 147,449,000USD | 72,899,000USD |
| Total Other Income Expense Net | -58,895,000USD | -59,759,000USD | -59,887,000USD | -3,394,000USD | -23,675,000USD | -36,538,000USD | -40,209,000USD | 7,641,000USD |
| Minority Interest | -35,699,000USD | -36,043,000USD | -25,340,000USD | 22,958,000USD | 19,592,000USD | 92,560,000USD | 8,684,000USD | 5,890,000USD |
| Research Development | — | — | 1,308,000USD | — | — | — | — | 0USD |
| Selling General Administrative | — | — | — | 1,265,292,000USD | 1,124,018,000USD | 970,255,000USD | 1,001,311,000USD | 869,478,000USD |
| Non Operating Income Net Other | — | — | — | 47,447,000USD | 25,155,000USD | 9,344,000USD | 7,835,000USD | 51,097,000USD |
| Net Income Applicable To Common Shares | — | — | — | 10,650,000USD | 24,727,000USD | -14,840,000USD | 14,756,000USD | 32,243,000USD |
| Interest Income | — | — | — | — | — | — | 39,694,000USD | 39,539,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,226,351,000USD | 3,885,389,000USD | 3,758,563,000USD | 3,665,279,000USD | 3,514,966,000USD | 3,336,264,000USD | 3,286,690,000USD | 3,275,342,000USD |
| Cash And Equivalents | 726,272,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,035,756,000USD | 740,775,000USD | 1,032,127,000USD | 1,077,777,000USD | 1,094,379,000USD | 1,015,861,000USD | 1,019,252,000USD | 1,016,253,000USD |
| Other Current Assets | 60,776,000USD | 76,346,000USD | 64,595,000USD | 62,513,000USD | 48,277,000USD | 63,526,000USD | 51,542,000USD | 38,051,000USD |
| Total Liabilities | 2,832,300,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 697,822,000USD | 635,634,000USD | 586,763,000USD | 574,914,000USD | 546,210,000USD | 505,399,000USD | 479,712,000USD | 470,130,000USD |
| Other Non Current Liabilities | 12,994,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,096,092,000USD | 1,080,551,000USD | 1,089,890,000USD | 1,058,540,000USD | 932,314,000USD | 898,139,000USD | 902,308,000USD | 895,313,000USD |
| Total Equity Including Noncontrolling Interest | 1,394,051,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 30,669,000USD | 26,506,000USD | 25,424,000USD | 25,454,000USD | 25,484,000USD | 24,677,000USD | 24,692,000USD | 23,378,000USD |
| Long Term Debt | 1,301,862,000USD | 1,059,977,000USD | 1,064,495,000USD | 1,070,886,000USD | 1,077,251,000USD | 985,454,000USD | 991,574,000USD | 996,272,000USD |
| Deferred Revenue | 16,480,000USD | — | — | — | — | — | — | — |
| Net Receivables | 241,845,000USD | 209,090,000USD | 200,317,000USD | 210,548,000USD | 212,950,000USD | 235,012,000USD | 227,690,000USD | 229,286,000USD |
| Property Plant Equipment Net | 1,639,129,000USD | 3,246,064,000USD | 2,995,904,000USD | 1,455,832,000USD | 2,814,872,000USD | 1,374,002,000USD | 1,334,531,000USD | 1,310,617,000USD |
| Goodwill | 1,122,468,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 245,348,000USD | 253,481,000USD | 148,508,000USD | 124,912,000USD | 91,078,000USD | 79,736,000USD | 81,351,000USD | 84,441,000USD |
| Accounts Payable | 489,818,000USD | 454,602,000USD | 422,029,000USD | 419,207,000USD | 406,689,000USD | 368,000,000USD | 96,450,000USD | 338,737,000USD |
| Short Term Debt | 69,557,000USD | 93,097,000USD | 87,358,000USD | 85,789,000USD | 144,558,000USD | 82,573,000USD | 81,310,000USD | 82,129,000USD |
| Common Stock | 8,000USD | 8,000USD | 8,000USD | 8,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -121,373,000USD | -128,903,000USD | -95,437,000USD | -94,840,000USD | -100,257,000USD | -114,711,000USD | -76,785,000USD | -82,130,000USD |
| Accumulated Other Comprehensive Income | -5,504,000USD | -2,466,000USD | 4,885,000USD | 5,969,999USD | 6,627,000USD | -3,919,000USD | -9,061,000USD | -1,843,000USD |
| Total Liab | — | 2,532,677,000USD | 2,402,677,000USD | 2,351,320,000USD | 2,335,705,000USD | 2,199,747,000USD | 2,153,280,000USD | 2,155,708,000USD |
| Other Current Liab | — | 75,960,000USD | 70,104,000USD | 69,918,000USD | -8,470,000USD | 51,410,000USD | 298,664,000USD | 44,872,000USD |
| Capital Stock | — | 8,000USD | 8,000USD | 8,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD |
| Good Will | — | 1,094,699,000USD | 907,663,000USD | 827,532,000USD | 751,514,000USD | 717,480,000USD | 710,663,000USD | 711,841,000USD |
| Cash | — | 455,339,000USD | 767,215,000USD | 804,716,000USD | 833,152,000USD | 717,323,000USD | 740,020,000USD | 748,916,000USD |
| Cash And Short Term Investments | — | 455,339,000USD | 767,215,000USD | 804,716,000USD | 833,152,000USD | 717,323,000USD | 740,020,000USD | 748,916,000USD |
| Current Deferred Revenue | — | 11,975,000USD | 7,272,000USD | — | 3,433,000USD | 3,416,000USD | 3,288,000USD | 4,392,000USD |
| Net Debt | — | 1,479,019,000USD | 1,091,639,000USD | 1,042,894,000USD | 1,067,440,000USD | 1,028,733,000USD | 988,843,000USD | 987,919,000USD |
| Short Long Term Debt Total | — | 1,934,358,000USD | 1,858,854,000USD | 1,847,610,000USD | 1,900,592,000USD | 1,746,056,000USD | 1,728,863,000USD | 1,736,835,000USD |
| Long Term Investments | — | 131,409,000USD | 130,340,000USD | 129,127,000USD | 125,804,000USD | 110,803,000USD | 104,057,000USD | 104,514,000USD |
| Property Plant Equipment Gross | — | 1,623,032,000USD | 2,449,866,000USD | 1,455,832,000USD | 1,407,436,000USD | 1,374,002,000USD | 2,270,190,000USD | 1,310,617,000USD |
| Common Stock Shares Outstanding | — | 77,057,835shares | 75,189,872shares | 74,703,658shares | 74,070,438shares | 74,382,000shares | 75,537,595shares | 75,165,435shares |
| Non Current Assets Total | — | 3,144,614,000USD | 2,726,436,000USD | 2,587,502,000USD | 2,420,587,000USD | 2,320,403,000USD | 2,267,438,000USD | 2,259,089,000USD |
| Non Current Liabilities Total | — | 1,897,043,000USD | 1,815,914,000USD | 1,776,406,000USD | 1,789,495,000USD | 1,694,348,000USD | 1,673,568,000USD | 1,685,578,000USD |
| Non Current Liabilities Other | — | 21,632,000USD | 22,515,000USD | 14,585,000USD | 12,020,000USD | 3,310,000USD | 3,785,000USD | 10,077,000USD |
| Non Currrent Assets Other | — | -1,581,038,999USD | -1,455,979,000USD | 50,099,000USD | -1,362,681,000USD | 38,382,000USD | 36,836,000USD | 47,676,000USD |
| Net Working Capital | — | 105,141,000USD | 445,364,000USD | 502,863,000USD | 548,169,000USD | 510,462,000USD | 539,540,000USD | 546,123,000USD |
| Unclassified Non Current Assets | — | -1,581,039,000USD | -1,455,979,000USD | — | -1,362,681,000USD | — | — | — |
| Unclassified Current Liabilities | — | -26,506,000USD | -25,424,000USD | -25,454,000USD | -33,954,000USD | -24,677,000USD | -24,692,000USD | -23,378,000USD |
| Unclassified Non Current Liabilities | — | 815,434,000USD | 728,904,000USD | 690,935,000USD | 700,224,000USD | 705,584,000USD | 678,209,000USD | 679,229,000USD |
| Unclassified Equity | — | 1,211,904,000USD | 1,180,426,000USD | 1,147,394,001USD | 1,025,928,000USD | 1,016,755,000USD | 988,140,000USD | 979,272,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,758,563,000USD | 3,286,690,000USD | 2,690,473,000USD | 2,433,907,000USD | 2,058,474,000USD | 1,786,657,000USD | 1,645,607,000USD | 1,109,330,000USD |
| Intangible Assets | 148,508,000USD | 81,351,000USD | 90,615,000USD | 106,228,000USD | 56,603,000USD | 52,393,000USD | 42,994,000USD | 40,593,000USD |
| Other Current Assets | 64,595,000USD | 51,542,000USD | 47,657,000USD | 54,022,000USD | 49,212,000USD | 32,985,000USD | 43,625,000USD | 48,787,000USD |
| Total Liab | 2,402,677,000USD | 2,153,280,000USD | 1,877,114,000USD | 1,942,455,000USD | 1,712,317,000USD | 1,528,354,000USD | 1,412,468,000USD | 909,077,000USD |
| Total Stockholder Equity | 1,089,890,000USD | 902,308,000USD | 630,695,000USD | 332,995,000USD | 228,904,000USD | 165,743,000USD | 151,685,000USD | 127,184,000USD |
| Other Current Liab | 70,104,000USD | 298,664,000USD | 235,962,000USD | 290,017,000USD | 201,006,000USD | 180,623,000USD | 91,764,000USD | 124,198,000USD |
| Common Stock | 8,000USD | 7,000USD | 7,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Capital Stock | 8,000USD | 7,000USD | 7,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -95,437,000USD | -76,785,000USD | -79,578,000USD | -82,622,000USD | -93,272,000USD | -117,999,000USD | -103,159,000USD | -117,915,000USD |
| Good Will | 907,663,000USD | 710,663,000USD | 679,463,000USD | 677,665,000USD | 513,820,000USD | 472,879,000USD | 440,981,000USD | 418,093,000USD |
| Cash | 767,215,000USD | 740,020,000USD | 342,570,000USD | 127,834,000USD | 134,606,000USD | 102,018,000USD | 40,165,000USD | 10,389,000USD |
| Cash And Short Term Investments | 767,215,000USD | 740,020,000USD | 342,570,000USD | 127,834,000USD | 134,606,000USD | 102,018,000USD | 40,165,000USD | 10,389,000USD |
| Total Current Assets | 1,032,127,000USD | 1,019,252,000USD | 579,276,000USD | 367,184,000USD | 324,264,000USD | 270,424,000USD | 241,836,000USD | 208,690,000USD |
| Total Current Liabilities | 586,763,000USD | 479,712,000USD | 437,452,000USD | 466,723,000USD | 374,784,000USD | 398,114,000USD | 326,049,000USD | 239,517,000USD |
| Current Deferred Revenue | 7,272,000USD | 3,288,000USD | 4,647,000USD | 4,021,000USD | 10,701,000USD | 39,257,000USD | 1,316,000USD | 2,398,000USD |
| Net Debt | 1,091,639,000USD | 988,843,000USD | 1,148,550,000USD | 1,385,634,000USD | 1,263,183,000USD | 1,082,897,000USD | 1,205,394,000USD | 661,890,000USD |
| Short Term Debt | 87,358,000USD | 81,310,000USD | 73,955,000USD | 70,007,000USD | 76,616,000USD | 108,163,000USD | 168,669,000USD | 44,881,000USD |
| Short Long Term Debt | 25,424,000USD | 24,692,000USD | 17,974,000USD | 12,400,000USD | 11,164,000USD | 39,791,000USD | 39,691,000USD | 33,653,000USD |
| Short Long Term Debt Total | 1,858,854,000USD | 1,728,863,000USD | 1,491,120,000USD | 1,513,468,000USD | 1,397,789,000USD | 1,184,915,000USD | 1,245,559,000USD | 672,279,000USD |
| Long Term Debt | 1,064,495,000USD | 991,574,000USD | 812,068,000USD | 839,344,000USD | 743,498,000USD | 612,913,000USD | 652,704,000USD | 626,507,000USD |
| Long Term Investments | 130,340,000USD | 104,057,000USD | 92,710,000USD | 57,893,000USD | 42,229,000USD | 34,528,000USD | 34,470,000USD | 37,973,000USD |
| Net Receivables | 200,317,000USD | 227,690,000USD | 189,049,000USD | 185,328,000USD | 140,446,000USD | 135,421,000USD | 156,005,000USD | 149,514,000USD |
| Accounts Payable | 422,029,000USD | 96,450,000USD | 122,888,000USD | 102,678,000USD | 86,461,000USD | 70,071,000USD | 64,300,000USD | 68,040,000USD |
| Property Plant Equipment Net | 2,995,904,000USD | 1,334,531,000USD | 1,200,433,000USD | 1,169,485,000USD | 1,068,538,000USD | 882,996,000USD | 812,223,000USD | 345,729,000USD |
| Property Plant Equipment Gross | 2,449,866,000USD | 2,270,190,000USD | 2,037,332,000USD | 1,169,485,000USD | 1,068,538,000USD | 882,996,000USD | 812,223,000USD | 345,729,000USD |
| Accumulated Other Comprehensive Income | 4,885,000USD | -9,061,000USD | -12,484,000USD | -20,677,000USD | -20,421,000USD | -24,051,000USD | -8,026,000USD | 2,259,000USD |
| Common Stock Shares Outstanding | 75,189,872shares | 74,762,332shares | 64,658,299shares | 57,320,870shares | 53,421,033shares | 50,891,791shares | 50,244,006shares | 48,678,999shares |
| Non Current Assets Total | 2,726,436,000USD | 2,267,438,000USD | 2,111,197,000USD | 2,066,723,000USD | 1,734,210,000USD | 1,516,233,000USD | 1,403,771,000USD | 900,640,000USD |
| Non Current Liabilities Total | 1,815,914,000USD | 1,673,568,000USD | 1,439,662,000USD | 1,475,732,000USD | 1,337,533,000USD | 1,130,240,000USD | 1,086,419,000USD | 669,560,000USD |
| Non Current Liabilities Other | 22,515,000USD | 3,785,000USD | 6,721,000USD | 23,015,000USD | 594,035,000USD | 53,488,000USD | 433,715,000USD | 5,006,000USD |
| Non Currrent Assets Other | -1,455,979,000USD | 36,836,000USD | 47,976,000USD | -160,864,000USD | 38,167,000USD | 38,750,000USD | 38,555,000USD | 26,746,000USD |
| Net Working Capital | 445,364,000USD | 539,540,000USD | 141,824,000USD | -99,539,000USD | -50,520,000USD | -127,690,000USD | -84,213,000USD | -30,827,000USD |
| Unclassified Non Current Assets | -1,455,979,000USD | — | — | — | -38,167,000USD | -38,750,000USD | -38,555,000USD | 31,506,000USD |
| Unclassified Current Liabilities | -25,424,000USD | -24,692,000USD | -17,974,000USD | -12,400,000USD | -11,164,000USD | -39,791,000USD | -39,691,000USD | -33,653,000USD |
| Unclassified Non Current Liabilities | 728,904,000USD | 678,209,000USD | 620,873,000USD | 578,822,000USD | -18,495,000USD | 408,584,000USD | -11,088,000USD | -30,043,000USD |
| Unclassified Equity | 1,180,426,000USD | 988,140,000USD | 722,743,000USD | 436,282,000USD | 342,587,000USD | 307,783,000USD | 262,860,000USD | 242,830,000USD |
| Inventory | — | — | 1USD | — | — | 1USD | 2,041,000USD | 2,499,000USD |
| Deferred Long Term Liab | — | — | — | 2,280,000USD | 2,135,000USD | 1,767,000USD | 1,559,000USD | 31,542,000USD |
| Other Liab | — | — | — | 32,271,000USD | 16,360,000USD | 53,488,000USD | 9,529,000USD | 36,548,000USD |
| Other Assets | — | — | — | 55,452,000USD | 53,020,000USD | 73,437,000USD | 73,103,000USD | -73,876,000USD |
| Net Tangible Assets | — | — | — | -450,898,000USD | -341,519,000USD | -359,529,000USD | -332,290,000USD | -331,502,000USD |
| Short Term Investments | — | — | — | — | — | 34,528,000USD | — | 3,316,000USD |
| Unclassified Current Assets | — | — | — | — | — | -34,528,001USD | — | -5,815,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 90,496,000USD |
| Stock Based Compensation | 41,915,000USD |
| Other Non Cash Items | -407,000USD |
| Change To Account Receivables | -23,413,000USD |
| Change To Liabilities | 74,574,000USD |
| Change In Working Capital | 44,734,000USD |
| Operating Cash Flow | 173,071,000USD |
| Investing Cash Flow | -434,527,000USD |
| Net Debt Issuance | 248,937,000USD |
| Common Stock Issuance | 612,000USD |
| Other Financing Activities | -3,927,000USD |
| Unclassified Financing Cash Flow | -22,907,000USD |
| Financing Cash Flow | 222,715,000USD |
| Effect Of Forex Changes On Cash | -2,202,000USD |
| Change In Cash | -40,943,000USD |
| End Cash Flow | 726,272,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -33,466,000USD | 9,861,000USD | 13,889,000USD | 14,454,000USD | -29,737,000USD | 14,225,000USD | 12,256,000USD | 6,945,000USD |
| Depreciation | 44,967,000USD | 40,852,000USD | 39,799,000USD | 36,736,000USD | 35,483,000USD | 96,568,000USD | 34,979,000USD | 34,475,000USD |
| Stock Based Compensation | 31,375,000USD | 8,325,000USD | 9,041,000USD | 8,741,000USD | 28,494,000USD | 8,465,000USD | 4,723,000USD | 4,748,000USD |
| Other Non Cash Items | 55,944,000USD | 11,508,000USD | 18,490,000USD | 44,294,000USD | 21,489,000USD | -36,752,000USD | 21,799,000USD | 24,586,000USD |
| Change To Account Receivables | 9,375,000USD | 10,916,000USD | -6,317,000USD | 147,000USD | -14,306,000USD | 13,602,000USD | -3,788,000USD | -5,716,000USD |
| Change In Working Capital | 24,826,000USD | 2,792,000USD | -28,392,000USD | 16,123,000USD | -14,248,000USD | -39,977,000USD | -16,353,000USD | 45,248,000USD |
| Total Cash From Operating Activities | 92,271,000USD | 84,164,000USD | 52,827,000USD | 120,348,000USD | 41,481,000USD | 42,529,000USD | 57,404,000USD | 116,005,000USD |
| Capital Expenditures | -69,932,000USD | -315,027,000USD | -60,445,000USD | -52,943,000USD | -48,833,000USD | -42,906,000USD | -41,069,000USD | -46,686,000USD |
| Free Cash Flow | 22,339,000USD | -230,863,000USD | -7,618,000USD | 67,405,000USD | -7,352,000USD | -377,000USD | 16,335,000USD | 69,319,000USD |
| Total Cashflows From Investing Activities | -370,973,000USD | -113,940,000USD | -75,724,000USD | -97,450,000USD | -56,751,000USD | -48,813,000USD | -45,979,000USD | -77,341,000USD |
| Net Borrowings | -15,205,000USD | -7,048,000USD | -7,020,000USD | 92,006,000USD | -6,718,000USD | -5,813,000USD | -7,663,000USD | — |
| Total Cash From Financing Activities | -30,803,000USD | -7,395,000USD | -5,316,000USD | 92,428,000USD | -7,510,000USD | -2,119,000USD | -4,335,000USD | 176,106,000USD |
| Change In Cash | -311,876,000USD | -37,501,000USD | -28,436,000USD | 115,829,000USD | -22,697,000USD | -8,896,000USD | 7,237,000USD | 214,699,000USD |
| Begin Period Cash Flow | 767,215,000USD | 804,716,000USD | 833,152,000USD | 717,323,000USD | 740,020,000USD | 748,916,000USD | 741,679,000USD | 526,980,000USD |
| End Period Cash Flow | 455,339,000USD | 767,215,000USD | 804,716,000USD | 833,152,000USD | 717,323,000USD | 740,020,000USD | 748,916,000USD | 741,679,000USD |
| Other Cashflows From Investing Activities | 2,833,000USD | 292,295,999USD | 2,867,000USD | -16,316,000USD | 23,000USD | 6,000USD | 142,000USD | 7,000USD |
| Other Cashflows From Financing Activities | -2,402,000USD | -3,538,000USD | 1,704,000USD | 99,423,000USD | -792,000USD | 3,694,000USD | 3,328,000USD | -6,037,000USD |
| Unclassified Operating Cash Flow | -31,375,000USD | 10,826,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -303,874,000USD | -91,208,999USD | 57,578,000USD | 69,259,000USD | 48,810,000USD | 42,900,000USD | 40,927,000USD | 46,679,000USD |
| Unclassified Financing Cash Flow | -13,196,000USD | 3,191,000USD | — | -99,001,000USD | — | — | — | 182,141,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 2,000USD |
| Investments | — | — | -75,724,000USD | -97,450,000USD | -56,751,000USD | -48,813,000USD | -45,979,000USD | -77,341,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 46,771,000USD | 38,836,000USD | 30,337,000USD | 33,608,000USD | 44,319,000USD | -1,749,000USD | 23,440,000USD | 38,133,000USD |
| Depreciation | 152,127,000USD | 198,390,000USD | 189,493,000USD | 184,724,000USD | 170,661,000USD | 154,710,000USD | 147,449,000USD | 72,899,000USD |
| Stock Based Compensation | 54,601,000USD | 29,833,000USD | 26,785,000USD | 23,770,000USD | 25,203,000USD | 12,405,000USD | 8,730,000USD | 7,662,000USD |
| Other Non Cash Items | 44,243,000USD | 22,452,000USD | 14,518,000USD | -50,345,000USD | 22,929,000USD | 13,531,000USD | 2,553,000USD | -13,354,000USD |
| Change To Account Receivables | -9,560,000USD | -21,767,000USD | 2,650,000USD | -30,078,000USD | -5,890,000USD | 25,206,000USD | -17,482,000USD | 2,145,000USD |
| Change In Working Capital | -9,750,000USD | -56,488,000USD | -40,270,000USD | -58,696,000USD | -92,128,000USD | 54,862,000USD | -77,850,000USD | 18,349,000USD |
| Total Cash From Operating Activities | 298,820,000USD | 233,023,000USD | 220,863,000USD | 146,417,000USD | 149,491,000USD | 233,759,000USD | 104,322,000USD | 116,754,000USD |
| Capital Expenditures | -213,251,000USD | -188,070,000USD | -176,600,000USD | -249,412,000USD | -220,695,000USD | -125,437,000USD | -101,303,000USD | -145,372,000USD |
| Free Cash Flow | 85,569,000USD | 44,953,000USD | 44,263,000USD | -102,995,000USD | -71,204,000USD | 108,322,000USD | 3,019,000USD | -28,618,000USD |
| Total Cashflows From Investing Activities | -343,865,000USD | -233,070,000USD | -201,470,000USD | -246,949,000USD | -221,511,000USD | -126,244,000USD | -99,465,000USD | -146,749,000USD |
| Net Borrowings | 71,220,000USD | 165,331,000USD | -43,993,000USD | 94,246,000USD | 94,476,000USD | -42,835,000USD | 21,908,000USD | -11,902,000USD |
| Total Cash From Financing Activities | 72,207,000USD | 397,950,000USD | 195,635,000USD | 93,647,000USD | 104,673,000USD | -45,561,000USD | 24,951,000USD | -10,869,000USD |
| Issuance Of Capital Stock | 0USD | 218,385,000USD | 245,832,000USD | 0USD | 0USD | — | — | — |
| Change In Cash | 27,195,000USD | 397,450,000USD | 214,736,000USD | -6,772,000USD | 32,588,000USD | 61,853,000USD | 29,776,000USD | -40,933,000USD |
| Begin Period Cash Flow | 740,020,000USD | 342,570,000USD | 127,834,000USD | 134,606,000USD | 102,018,000USD | 40,165,000USD | 10,389,000USD | 51,322,000USD |
| End Period Cash Flow | 767,215,000USD | 740,020,000USD | 342,570,000USD | 127,834,000USD | 134,606,000USD | 102,018,000USD | 40,165,000USD | 10,389,000USD |
| Other Cashflows From Investing Activities | 2,808,000USD | 157,000USD | 83,000USD | 3,904,000USD | 625,000USD | 828,000USD | 1,952,000USD | 248,000USD |
| Other Cashflows From Financing Activities | -4,462,000USD | 14,234,000USD | -6,204,000USD | -893,000USD | 9,709,000USD | -2,726,000USD | 3,043,000USD | 1,033,000USD |
| Unclassified Operating Cash Flow | 10,828,000USD | — | — | 13,356,000USD | -21,493,000USD | — | — | -6,935,000USD |
| Unclassified Investing Cash Flow | -133,422,000USD | 187,913,000USD | 251,771,000USD | — | — | 124,609,000USD | — | 2,575,000USD |
| Unclassified Financing Cash Flow | 5,449,000USD | — | — | — | 8,686,000USD | 3,562,000USD | 2,982,000USD | 3,034,000USD |
| Investments | — | -233,070,000USD | -276,724,000USD | -1,441,000USD | -1,441,000USD | -126,244,000USD | 678,000USD | -4,200,000USD |
| Change To Liabilities | — | — | — | 42,462,000USD | 1,430,000USD | 82,399,000USD | 16,234,000USD | 27,762,000USD |
| Sale Purchase Of Stock | — | — | — | -599,000USD | -1,938,000USD | -1,985,000USD | -2,982,000USD | -1,607,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -6,885,000USD | 32,653,000USD | 61,954,000USD | 29,776,000USD | -40,933,000USD |
| Change To Inventory | — | — | — | — | -87,668,000USD | -45,069,000USD | -17,316,000USD | -10,935,000USD |
| Dividends Paid | — | — | — | — | -6,260,000USD | -1,577,000USD | — | -1,427,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | -32,000USD | -69,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Capitation Arrangements | 30,413,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Management Service | 7,481,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Other | 24,804,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Commercial Insurance1 | 315,869,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Medicaid1 | 13,991,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Medicare1 | 137,179,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Other Payors | 43,895,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 12,304,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Digital Health | 18,816,000 | USD | 0001628280-26-033607 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Imaging Centers | 556,815,000 | USD | 0001628280-26-033607 |
| Q4 2025Quarterly · 2025-12-31 | Product | Capitation Arrangements | 31,877,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Management Service | 7,505,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Other | 20,389,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Patient Service — Commercial Insurance1 | 300,955,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Patient Service — Medicaid1 | 13,979,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Patient Service — Medicare1 | 129,203,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Patient Service — Other Payors | 43,127,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 12,252,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Digital Health | 16,355,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Imaging Centers | 531,357,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 33,973,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 2,006,237,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Capitation Arrangements | 125,537,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Management Service | 27,516,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Other | 65,021,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Patient Service — Commercial Insurance1 | 1,130,114,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Patient Service — Medicaid1 | 51,736,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Patient Service — Medicare1 | 476,987,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Patient Service — Other Payors | 159,273,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 44,700,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Segment | Digital Health | 52,017,000 | USD | 0001628280-26-013337 |
| FY 2025Yearly · 2025-12-31 | Segment | Imaging Centers | 1,988,193,000 | USD | 0001628280-26-013337 |
| Q3 2025Quarterly · 2025-09-30 | Product | Capitation Arrangements | 31,443,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Management Service | 7,044,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Other | 18,580,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Patient Service — Commercial Insurance1 | 287,769,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Patient Service — Medicaid1 | 13,470,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Patient Service — Medicare1 | 123,254,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Patient Service — Other Payors | 40,149,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 11,347,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Digital Health | 14,627,000 | USD | 0000790526-25-000008 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Imaging Centers | 508,242,000 | USD | 0000790526-25-000008 |
| Q2 2025Quarterly · 2025-06-30 | Product | Capitation Arrangements | 30,167,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Management Service | 6,688,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Other | 13,509,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Patient Service — Commercial Insurance1 | 278,902,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Patient Service — Medicaid1 | 12,597,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Patient Service — Medicare1 | 116,331,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Patient Service — Other Payors | 39,106,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 10,642,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Digital Health | 11,014,000 | USD | 0001628280-25-039605 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Imaging Centers | 487,216,000 | USD | 0001628280-25-039605 |
| Q1 2025Quarterly · 2025-03-31 | Product | Capitation Arrangements | 32,050,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Management Service | 6,279,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Other | 12,543,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Commercial Insurance1 | 262,488,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Medicaid1 | 11,690,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Medicare1 | 108,199,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Other Payors | 36,891,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 10,459,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Digital Health | 10,021,000 | USD | 0001628280-26-033607 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Imaging Centers | 461,378,000 | USD | 0001628280-26-033607 |
| Q4 2024Quarterly · 2024-12-31 | Product | Capitation Arrangements | 31,525,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Management Service | 6,421,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Other | 11,210,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Patient Service — Commercial Insurance1 | 265,805,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Patient Service — Medicaid1 | 11,954,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Patient Service — Medicare1 | 111,975,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Patient Service — Other Payors | 35,778,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 10,642,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Digital Health | 10,641,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Imaging Centers | 466,461,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Other Countries | 2,883,000 | USD | 0001628280-25-009481 |
| FY 2024Yearly · 2024-12-31 | Geography | United Kingdom | 24,359,000 | USD | 0001628280-25-009481 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 1,802,422,000 | USD | 0001628280-25-009481 |
| FY 2024Yearly · 2024-12-31 | Product | Capitation Arrangements | 136,575,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Management Service | 24,676,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Other | 46,724,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Patient Service — Commercial Insurance1 | 1,018,327,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Patient Service — Medicaid1 | 44,736,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Patient Service — Medicare1 | 410,072,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Patient Service — Other Payors | 133,249,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 43,666,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Segment | Digital Health | 37,345,000 | USD | 0001628280-26-013337 |
| FY 2024Yearly · 2024-12-31 | Segment | Imaging Centers | 1,792,319,000 | USD | 0001628280-26-013337 |
| Q3 2024Quarterly · 2024-09-30 | Product | Capitation Arrangements | 33,563,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Management Service | 6,241,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Other | 16,616,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Patient Service — Commercial Insurance1 | 255,376,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Patient Service — Medicaid1 | 10,894,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Patient Service — Medicare1 | 102,853,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Patient Service — Other Payors | 32,959,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Patient Service — Workers Compensation Personal Injury1 | 10,233,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Digital Health | 8,774,000 | USD | 0000790526-25-000008 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Imaging Centers | 452,367,000 | USD | 0000790526-25-000008 |
| Q2 2024Quarterly · 2024-06-30 | Product | Capitation Arrangements | 36,969,000 | USD | 0001628280-25-039605 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Management Service | 6,106,000 | USD | 0001628280-25-039605 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Other | 9,837,000 | USD | 0001628280-25-039605 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Patient Service — Commercial Insurance1 | 256,517,000 | USD | 0001628280-25-039605 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Patient Service — Medicaid1 | 11,001,000 | USD | 0001628280-25-039605 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.